title: Improved overall survival following tyrosine kinase inhibitor (TKI) treatment in NSCLC-are we making progress?
authors.affiliation: Medical School Hamburg (MSH), Hamburg, and Praxisklinik Saalfeld/Saale, Germany ;
authors.forename: Klaus
authors.initials: K
authors.lastname: Fenchel
authors.affiliation: Kyowa Kirin Pharmaceutical Development Ltd, Galashiels, UK ;
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Dale
authors.affiliation: Kyowa Kirin Pharmaceutical Development Ltd, Galashiels, UK;; University Hospital of Grosshadern (LMU Munich, Haematology and Oncology), Munich, Germany.
authors.forename: Wolfram C M
authors.initials: WC
authors.lastname: Dempke